CN Patent

CN114644595A — 阿普昔腾坦的无定型态、其药物组合物和用途

Assigned to Seasons Biotechnology Taizhou Co Ltd · Expires 2022-06-21 · 4y expired

What this patent protects

本申请公开了阿普昔腾坦的无定型态、其药物组合物和用途，所述阿普昔腾坦的无定型态在溶解度方面具有优势；所述阿普昔腾坦的药物组合物包含阿普昔腾坦固体分散体，制备得到的阿普昔腾坦固体分散体显著改善了溶出度，确保药效。

USPTO Abstract

本申请公开了阿普昔腾坦的无定型态、其药物组合物和用途，所述阿普昔腾坦的无定型态在溶解度方面具有优势；所述阿普昔腾坦的药物组合物包含阿普昔腾坦固体分散体，制备得到的阿普昔腾坦固体分散体显著改善了溶出度，确保药效。

Drugs covered by this patent

Patent Metadata

Patent number
CN114644595A
Jurisdiction
CN
Classification
—
Expires
2022-06-21
Drug substance claim
No
Drug product claim
No
Assignee
Seasons Biotechnology Taizhou Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.